1887

Abstract

The human prion protein (PrP) has a common polymorphism at residue 129, which can be valine or methionine. This polymorphism has a strong influence on susceptibility to prion diseases and on prion-strain properties. Previous work has shown that this amino acid variation has no measurable effect on the native structure of cellular PrP (PrP). Here, it is shown that the polymorphism does not change the efficiency of conversion to the -PrP conformation or affect the binding of copper(II) ions. However, in a partially denatured conformation, the polymorphic variation has a profound influence on the ability of the protein to form amyloid fibrils spontaneously.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.81630-0
2006-08-01
2019-11-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/87/8/2443.html?itemId=/content/journal/jgv/10.1099/vir.0.81630-0&mimeType=html&fmt=ahah

References

  1. Asante, E. A., Linehan, J. M., Desbruslais, M. & 8 other authors ( 2002; ). BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein. EMBO J 21, 6358–6366.[CrossRef]
    [Google Scholar]
  2. Baskakov, I. V. ( 2004; ). Autocatalytic conversion of recombinant prion proteins displays a species barrier. J Biol Chem 279, 7671–7677.[CrossRef]
    [Google Scholar]
  3. Baskakov, I. V., Legname, G., Baldwin, M. A., Prusiner, S. B. & Cohen, F. E. ( 2002; ). Pathway complexity of prion protein assembly into amyloid. J Biol Chem 277, 21140–21148.[CrossRef]
    [Google Scholar]
  4. Baskakov, I., Disterer, P., Breydo, L., Shaw, M., Gill, A., James, W. & Tahiri-Alaoui, A. ( 2005; ). The presence of valine at residue 129 in human prion protein accelerates amyloid formation. FEBS Lett 579, 2589–2596.[CrossRef]
    [Google Scholar]
  5. Collinge, J. ( 1999; ). Variant Creutzfeldt-Jakob disease. Lancet 354, 317–323.[CrossRef]
    [Google Scholar]
  6. Collinge, J. ( 2001; ). Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 24, 519–550.[CrossRef]
    [Google Scholar]
  7. Collinge, J., Palmer, M. S. & Dryden, A. J. ( 1991; ). Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease. Lancet 337, 1441–1442.[CrossRef]
    [Google Scholar]
  8. Collinge, J., Palmer, M. S., Sidle, K. C. L. & 7 other authors ( 1995; ). Unaltered susceptibility to BSE in transgenic mice expressing human prion protein. Nature 378, 779–783.[CrossRef]
    [Google Scholar]
  9. Collinge, J., Beck, J., Campbell, T., Estibeiro, K. & Will, R. G. ( 1996a; ). Prion protein gene analysis in new variant cases of Creutzfeldt-Jakob disease. Lancet 348, 56.
    [Google Scholar]
  10. Collinge, J., Sidle, K. C. L., Meads, J., Ironside, J. & Hill, A. F. ( 1996b; ). Molecular analysis of prion strain variation and the aetiology of ‘new variant’ CJD. Nature 383, 685–690.[CrossRef]
    [Google Scholar]
  11. Dawson, R. M. C., Elliot, D., Elliot, W. & Jones, K. M. ( 1986; ). Data for Biochemical Research, 3rd edn, pp. 399–415. Oxford: Clarendon Press.
  12. Dlouhy, S. R., Hsiao, K., Farlow, M. R., Foroud, T., Conneally, P. M., Johnson, P., Prusiner, S. B., Hodes, M. E. & Ghetti, B. ( 1992; ). Linkage of the Indiana kindred of Gerstmann–Sträussler–Scheinker disease to the prion protein gene. Nat Genet 1, 64–67.[CrossRef]
    [Google Scholar]
  13. Goldfarb, L. G., Petersen, R. B., Tabaton, M. & 18 other authors ( 1992; ). Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science 258, 806–808.[CrossRef]
    [Google Scholar]
  14. Grantham, R. ( 1974; ). Amino acid difference formula to help explain protein evolution. Science 185, 862–864.[CrossRef]
    [Google Scholar]
  15. Griffith, J. S. ( 1967; ). Self-replication and scrapie. Nature 215, 1043–1044.[CrossRef]
    [Google Scholar]
  16. Hainfellner, J. A., Parchi, P., Kitamoto, T., Jarius, C., Gambetti, P. & Budka, H. ( 1999; ). A novel phenotype in familial Creutzfeldt-Jakob disease: prion protein gene E200K mutation coupled with valine at codon 129 and type 2 protease-resistant prion protein. Ann Neurol 45, 812–816.[CrossRef]
    [Google Scholar]
  17. Hill, A. F. & Collinge, J. ( 2003; ). Subclinical prion infection. Trends Microbiol 11, 578–584.[CrossRef]
    [Google Scholar]
  18. Hill, A. F., Butterworth, R. J., Joiner, S. & 12 other authors ( 1999; ). Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 353, 183–189.[CrossRef]
    [Google Scholar]
  19. Hill, A. F., Joiner, S., Wadsworth, J. D. F., Sidle, K. C. L., Bell, J. E., Budka, H., Ironside, J. W. & Collinge, J. ( 2003; ). Molecular classification of sporadic Creutzfeldt–Jakob disease. Brain 126, 1333–1346.[CrossRef]
    [Google Scholar]
  20. Hosszu, L. L. P., Jackson, G. S., Trevitt, C. R. & 7 other authors ( 2004; ). The residue 129 polymorphism in human prion protein does not confer susceptibility to Creutzfeldt-Jakob disease by altering the structure or global stability of PrPC. J Biol Chem 279, 28515–28521.[CrossRef]
    [Google Scholar]
  21. Jackson, G. S., Hosszu, L. L. P., Power, A. & 7 other authors ( 1999; ). Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations. Science 283, 1935–1937.[CrossRef]
    [Google Scholar]
  22. Jackson, G. S., Murray, I., Hosszu, L. L. P., Gibbs, N., Waltho, J. P., Clarke, A. R. & Collinge, J. ( 2001; ). Location and properties of metal-binding sites on the human prion protein. Proc Natl Acad Sci U S A 98, 8531–8535.[CrossRef]
    [Google Scholar]
  23. Khalili-Shirazi, A., Quaratino, S., Londei, M., Summers, L., Tayebi, M., Clarke, A. R., Hawke, S. H., Jackson, G. S. & Collinge, J. ( 2005a; ). Protein conformation significantly influences immune responses to prion protein. J Immunol 174, 3256–3263.[CrossRef]
    [Google Scholar]
  24. Khalili-Shirazi, A., Summers, L., Linehan, J., Mallinson, G., Anstee, D., Hawke, S., Jackson, G. S. & Collinge, J. ( 2005b; ). PrP glycoforms are associated in a strain-specific ratio in native PrPSc. J Gen Virol 86, 2635–2644.[CrossRef]
    [Google Scholar]
  25. Lee, H.-S., Brown, P., Cervenáková, L., Garruto, R. M., Alpers, M. P., Gajdusek, D. C. & Goldfarb, L. G. ( 2001; ). Increased susceptibility to kuru of carriers of the PRNP 129 methionine/methionine genotype. J Infect Dis 183, 192–196.[CrossRef]
    [Google Scholar]
  26. Mead, S., Stumpf, M. P. H., Whitfield, J. & 8 other authors ( 2003; ). Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics. Science 300, 640–643.[CrossRef]
    [Google Scholar]
  27. Monari, L., Chen, S. G., Brown, P. & 12 other authors ( 1994; ). Fatal familial insomnia and familial Creutzfeldt–Jakob disease: different prion proteins determined by a DNA polymorphism. Proc Natl Acad Sci U S A 91, 2839–2842.[CrossRef]
    [Google Scholar]
  28. Nielsen, L., Frokjaer, S., Brange, J., Uversky, V. N. & Fink, A. L. ( 2001; ). Probing the mechanism of insulin fibril formation with insulin mutants. Biochemistry 40, 8397–8409.[CrossRef]
    [Google Scholar]
  29. Owen, F., Poulter, M., Collinge, J. & Crow, T. J. ( 1990; ). A codon 129 polymorphism in the PRIP gene. Nucleic Acids Res 18, 3103.
    [Google Scholar]
  30. Palmer, M. S., Dryden, A. J., Hughes, J. T. & Collinge, J. ( 1991; ). Homozygous prion protein genotype predisposes to sporadic Creutzfeldt–Jakob disease. Nature 352, 340–342.[CrossRef]
    [Google Scholar]
  31. Pan, K.-M., Baldwin, M., Nguyen, J. & 8 other authors ( 1993; ). Conversion of α-helices into β-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci U S A 90, 10962–10966.[CrossRef]
    [Google Scholar]
  32. Parker, M. J., Spencer, J. & Clarke, A. R. ( 1995; ). An integrated kinetic analysis of intermediates and transition states in protein folding reactions. J Mol Biol 253, 771–786.[CrossRef]
    [Google Scholar]
  33. Petraroli, R. & Pocchiari, M. ( 1996; ). Codon 219 polymorphism of PRNP in healthy Caucasians and Creutzfeldt-Jakob disease patients. Am J Hum Genet 58, 888–889.
    [Google Scholar]
  34. Poulter, M., Baker, H. F., Frith, C. D. & 13 other authors ( 1992; ). Inherited prion disease with 144 base pair gene insertion. 1. Genealogical and molecular studies. Brain 115, 675–685.[CrossRef]
    [Google Scholar]
  35. Prusiner, S. B. ( 1982; ). Novel proteinaceous infectious particles cause scrapie. Science 216, 136–144.[CrossRef]
    [Google Scholar]
  36. Prusiner, S. B. ( 1998; ). Prions. Proc Natl Acad Sci U S A 95, 13363–13383.[CrossRef]
    [Google Scholar]
  37. Prusiner, S. B., McKinley, M. P., Bowman, K. A., Bolton, D. C., Bendheim, P. E., Groth, D. F. & Glenner, G. G. ( 1983; ). Scrapie prions aggregate to form amyloid-like birefringent rods. Cell 35, 349–358.[CrossRef]
    [Google Scholar]
  38. Prusiner, S. B., Scott, M., Foster, D. & 8 other authors ( 1990; ). Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell 63, 673–686.[CrossRef]
    [Google Scholar]
  39. Shibuya, S., Higuchi, J., Shin, R. W., Tateishi, J. & Kitamoto, T. ( 1998; ). Codon 219 Lys allele of PRNP is not found in sporadic Creutzfeldt-Jakob disease. Ann Neurol 43, 826–828.[CrossRef]
    [Google Scholar]
  40. Tahiri-Alaoui, A., Gill, A. C., Disterer, P. & James, W. ( 2004; ). Methionine 129 variant of human prion protein oligomerizes more rapidly than the valine 129 variant: implications for disease susceptibility to Creutzfeldt-Jakob disease. J Biol Chem 279, 31390–31397.[CrossRef]
    [Google Scholar]
  41. Wadsworth, J. D. F., Hill, A. F., Joiner, S., Jackson, G. S., Clarke, A. R. & Collinge, J. ( 1999; ). Strain-specific prion-protein conformation determined by metal ions. Nat Cell Biol 1, 55–59.[CrossRef]
    [Google Scholar]
  42. Wadsworth, J. D. F., Asante, E. A., Desbruslais, M. & 9 other authors ( 2004; ). Human prion protein with valine 129 prevents expression of variant CJD phenotype. Science 306, 1793–1796.[CrossRef]
    [Google Scholar]
  43. Zeidler, M., Stewart, G., Cousens, S. N., Estebeiro, K. & Will, R. G. ( 1997; ). Codon 129 genotype and new variant CJD. Lancet 350, 668.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.81630-0
Loading
/content/journal/jgv/10.1099/vir.0.81630-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error